• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RVA
Click for more information
0.00% 0.0¢

REVA MEDICAL, INC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
RVAPreliminary Final ReportPRICE SENSITIVE29/02/12
RVAClinical Trial UpdatePRICE SENSITIVE17/02/12
RVAAppendix 4C - quarterlyPRICE SENSITIVE31/01/12
RVAREVA Commences Clinical TrialPRICE SENSITIVE22/12/11
RVAQuarterly Report on Form 10-QPRICE SENSITIVE15/11/11
RVAAppendix 4C - quarterlyPRICE SENSITIVE28/10/11
RVAHalf Yearly Report and Appendix 4DPRICE SENSITIVE16/08/11
RVAAppendix 4C for Quarter Ended 30 June 2011PRICE SENSITIVE01/08/11
RVAREVA Receives Clinical Trial ApprovalPRICE SENSITIVE24/05/11
RVAAppendix 4C - quarterlyPRICE SENSITIVE29/04/11
RVAPreliminary Final ReportPRICE SENSITIVE28/02/11
RVAAppendix 4C for Quarter Ended 31 December 2010PRICE SENSITIVE31/01/11
RVAAdmission to Official ListPRICE SENSITIVE21/12/10
RVAPreliminary Final Report
29/02/12PRICE SENSITIVE
RVAClinical Trial Update
17/02/12PRICE SENSITIVE
RVAAppendix 4C - quarterly
31/01/12PRICE SENSITIVE
RVAREVA Commences Clinical Trial
22/12/11PRICE SENSITIVE
RVAQuarterly Report on Form 10-Q
15/11/11PRICE SENSITIVE
RVAAppendix 4C - quarterly
28/10/11PRICE SENSITIVE
RVAHalf Yearly Report and Appendix 4D
16/08/11PRICE SENSITIVE
RVAAppendix 4C for Quarter Ended 30 June 2011
01/08/11PRICE SENSITIVE
RVAREVA Receives Clinical Trial Approval
24/05/11PRICE SENSITIVE
RVAAppendix 4C - quarterly
29/04/11PRICE SENSITIVE
RVAPreliminary Final Report
28/02/11PRICE SENSITIVE
RVAAppendix 4C for Quarter Ended 31 December 2010
31/01/11PRICE SENSITIVE
RVAAdmission to Official List
21/12/10PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
ASX Market Open: Futures say drop after Bullock's hawkish speech removes slow cut doubts | Nov 29, 2024 Good morning, and welcome to Week 48. The ASX 200 is expected to open down 0.45% as global trading slows through the U.S. break @ a trend retail shoppers will shrug off this weekend as Black Friday sales begin in earnest.With Wall Street shut for Thanksgiving, investors watched (but don&CloseCurl...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.